Fc gamma receptors and cross-presentation in dendritic cells.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

45 citing papers in PubMed, 122 citations in OpenAlex.

1. FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell Carcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2017
   Trial
2. Development of a coordinated allo T cell and auto B cell response against autosomal PTK2B after allogeneic hematopoietic stem cell transplantation.Haematologica · 2014
   Trial
3. Fc effector functions in RNA viral infections: mechanisms of antiviral immunity and implications for vaccine design.Frontiers in immunology · 2026
   Review
4. Cancer vaccines compensate for the insufficient induction of protective tumor-specific immunity of CD3 bispecific antibody therapy.Journal for immunotherapy of cancer · 2025
   Article
5. The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity.Cancers · 2024
   Review
6. C-Reactive Protein Suppresses the Th17 Response Indirectly by Attenuating the Antigen Presentation Ability of Monocyte Derived Dendritic Cells in Experimental Autoimmune Encephalomyelitis.Frontiers in immunology · 2021
   Article
7. The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease.Frontiers in immunology · 2019
   Review
8. The effect of the cholinergic anti-inflammatory pathway on collagen-induced arthritis involves the modulation of dendritic cell differentiation.Arthritis research & therapy · 2018
   Article
9. Identification of a Potential Common Ancestor for Mammalian Cross-Presenting Dendritic Cells in Teleost Respiratory Surfaces.Frontiers in immunology · 2018
   Article
10. Present Yourself! By MHC Class I and MHC Class II Molecules.Trends in immunology · 2016
    Review
11. Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains.Vaccine · 2016
    Article
12. Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis.European journal of immunology · 2015
    Article
13. Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases.Expert review of anti-infective therapy · 2015
    Review
14. Carbohydrate-mimetic peptides for pan anti-tumor responses.Frontiers in immunology · 2014
    Review
15. Dendritic cell-targeted vaccines.Frontiers in immunology · 2014
    Review
16. Immunoglobulin Fc fragment tagging allows strong activation of endogenous CD4 T cells to reshape the tumor milieu and enhance the antitumor effect of lentivector immunization.Journal of immunology (Baltimore, Md. : 1950) · 2012
    Article
17. Novel myeloma-associated antigens revealed in the context of syngeneic hematopoietic stem cell transplantation.Blood · 2012
    Article
18. Airway epithelial cells condition dendritic cells to express multiple immune surveillance genes.PloS one · 2012
    Article
19. Cross-presentation of cell-associated antigens by mouse splenic dendritic cell populations.Frontiers in immunology · 2012
    Article
20. Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention.Clinical and experimental immunology · 2011
    Review

Corrections and comments

• Comment on
  Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells.2002

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as